Argosy Research Capital Reinvestment Ratio

Latest as of March 2026: 0.21x

Argosy Research capital reinvestment ratio. Argosy Research (3217) has a Capital Reinvestment Ratio of 0.21x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$313.46 Million) in capital expenditures (NT$64.66 Million). Check Argosy Research investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.21x
Capex / Operating Cash Flow

Operating Cash Flow

NT$313.46 Million
TWD

Capital Expenditures

NT$64.66 Million
TWD

Data as of

Mar 2026
Most recent filing

Capital Reinvestment Ratio of Argosy Research (2017–2025)

Capital reinvestment ratio of Argosy Research from 2017 to 2025. This chart tracks Argosy Research's Capital Reinvestment Ratio across 9 annual periods. Also explore Argosy Research (3217) equity growth momentum to track the company's year-over-year net asset growth rate.

Argosy Research Capital Reinvestment Ratio by Year (2017–2025)

Argosy Research capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see Argosy Research operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 0.17x NT$1.26 Billion NT$217.61 Million ▲ +26.2%
2024 0.14x NT$1.01 Billion NT$138.32 Million ▼ -52.6%
2023 0.29x NT$764.74 Million NT$220.53 Million ▲ +72.3%
2022 0.17x NT$876.97 Million NT$146.78 Million ▼ -70.7%
2021 0.57x NT$595.58 Million NT$340.50 Million ▲ +149.4%
2020 0.23x NT$738.04 Million NT$169.17 Million ▲ +51.6%
2019 0.15x NT$572.03 Million NT$86.47 Million ▼ -48.2%
2018 0.29x NT$239.07 Million NT$69.82 Million ▲ +13.6%
2017 0.26x NT$351.05 Million NT$90.25 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow